Results 271 to 280 of about 73,620 (322)
Abstract T‐cell re‐directional therapies, including chimeric antigen receptor (CAR)‐T cell and bispecific antibodies (BsA), have transformed the treatment landscape to benefit patients with multiple myeloma. A number of these novel therapies has been approved internationally, with CAR‐T therapy recently approved in Australia.
P. Joy Ho, Eric W. Li
wiley +1 more source
Combining SKY92 gene expression profiling and FISH (according to R2-ISS) defines ultra-high-risk Multiple Myeloma. [PDF]
Zhou X+21 more
europepmc +1 more source
A review on pathobiology of circulating tumour plasma cells: The sine qua non of poor prognosis in plasma cell neoplasms. [PDF]
Suku P+4 more
europepmc +1 more source
Molecular techniques in haematopathology: what and how? [PDF]
Chatterjee G+4 more
europepmc +1 more source
Cytogenetics in retinoblastomas
Rao K, Rao C, Radhakrishna G
doaj
Cave-dwelling bats of Carajás National Forest: New cytogenetic data of threatened species. [PDF]
da Silva JB+6 more
europepmc +1 more source
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia. [PDF]
Galasso M+17 more
europepmc +1 more source
Clonal eosinophilia with exclusive pulmonary involvement driven by PDGFRA rearrangement treated with imatinib: A case report. [PDF]
Mlayah Z+5 more
europepmc +1 more source
International Journal of Laboratory Hematology, EarlyView.
Sara Sacchetti+4 more
wiley +1 more source
International Journal of Laboratory Hematology, EarlyView.
Katie Liston, Vitaliy Mykytiv
wiley +1 more source